Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between type-three metabotropic glutamate receptor gene (GRM3) variants and symptom presentation in treatment refractory schizophrenia.

Human psychopharmacology - 1 Jan 2011

Bishop Jeffrey R, Miller Del D, Ellingrod Vicki L, Holman Timothy

Abstract excerpt

OBJECTIVE: Positive associations between polymorphisms in the type-three metabotropic glutamate receptor gene (GRM3) and the pathogenesis of schizophrenia as well as response to antipsychotic treatment have been reported. The objective of this study was to determine whether refractory psychiatric...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Genotype
Share to Polymorphism, Single Nucleotide

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Psychiatric Status Rating Scales

Share to Receptors, Metabotropic Glutamate

Share to Schizophrenia

Share to Schizophrenic Psychology

Source

Open in PubMed Open full text

Identifiers

PMID: 21344500
DOI: 10.1002/hup.1163
PMCID: PMC3199025

Genes

GRM3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21344500-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between type-three metabotropic glutamate receptor gene (GRM3) variants and symptom presentation in treatment refractory schizophrenia.PMID 21344500Read ↗

Further evidence for a functional role of the glutamate receptor gene GRM3 in schizophrenia.Semantic proximity Read ↗

Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment.Semantic proximity Read ↗

Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia.Semantic proximity Read ↗

Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia.Semantic proximity Read ↗

No evidence for association between polymorphisms in GRM3 and schizophrenia.Semantic proximity Read ↗

Synergistic association of PI4KA and GRM3 genetic polymorphisms with poor antipsychotic response in south Indian schizophrenia patients with low severity of illness.Semantic proximity Read ↗

Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk.Semantic proximity Read ↗

Dopamine receptor D3 genotype association with greater acute positive symptom remission with olanzapine therapy in predominately caucasian patients with chronic schizophrenia or schizoaffective disorder.Semantic proximity Read ↗

Association between genetic variants of GRM7 (rs1396409 and rs9883258) and treatment outcomes in Schizophrenic Egyptian patients.Semantic proximity Read ↗

No association between the metabotropic glutamate receptor type 3 gene (GRM3) and schizophrenia in a Japanese population.Semantic proximity Read ↗

Psychosis and relapse in bipolar disorder are related to GRM3, DAOA, and GRIN2B genotype.Semantic proximity Read ↗

Association study of GRM7 polymorphisms and schizophrenia in the Chinese Han population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.